Of note, when galectin-1 was included in a panel with three other autoantibodies, the diagnostic value was comparable to a combination of the classical tumor markers CEA (carcinoembryonic antigen) and SCC-Ag (squamous cell carcinoma antigen), i.e., 32% and 40% sensitivity, respectively [43]. This evidence concerns the gene CEACAM5 and neoplasm.